Antitransforming growth factor-{beta} antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation
- Department of Radiation Oncology, Duke University Medical Center, Durham, NC (United States)
- Genzyme Corporation, Cambridge, MA (United States)
Purpose The aim of this study was to determine whether a neutralizing transforming growth factor-{beta} (TGF{beta}) antibody can prevent radiation (RT) induced lung injury. Methods and Materials Fractionated and sham right lung irradiation in Fischer 344 rats was delivered to assess the radioprotective effect of the antibodies. Animals were divided into the following groups: (1) control (sham RT, control antibody 13C4); (2) RT (800cGy x 5)+13C4); (3) RT + 0.1 mg/kg 1D11 anti-TGF{beta} antibody; and (4) RT + 1 mg/kg 1D11 antibody. Antibodies were intraperitoneally administered immediately after the last fraction of RT. Animals were sacrificed at 6 and 26 weeks after irradiation. Lungs were assessed for histologic changes, activation of macrophages, expression/activation of TGF{beta} and its signal transduction pathway. Results At 6 weeks post-RT, there was a significant reduction in macrophage accumulation (p = 0.041), alveolar wall thickness (p = 0.0003), and TGF-{beta} activation (p = 0.032) in animals receiving 1.0 mg/kg 1D11 vs. in the control group. However, at 6 weeks, the low dose of 1D11 antibody (0.1 mg/kg) failed to produce any significant changes. At 6 months post-RT, radioprotection is apparent for the group receiving 1.0 mg/kg 1D11, with activated macrophages (p = 0.037), alveolar wall thickness (p = 0.0002), TGF{beta} activation (p = 0.002) and its signal transduction proteins (p < 0.05) compared with the control group. Conclusions Administration of a single dose of 1.0 mg/kg of the anti-TGF{beta} antibody 1D11 resulted in decreased morphologic changes, inflammatory response, and reduced expression and activation of TGF{beta} 6 weeks and 6 months after 40 Gy to the right hemithorax. Targeting the TGF{beta} pathway may be a useful strategy to prevent radiation-induced lung injury.
- OSTI ID:
- 20842922
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 65, Issue 3; Other Information: DOI: 10.1016/j.ijrobp.2006.02.051; PII: S0360-3016(06)00392-0; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats
Radioprotective Effects of Amifostine on Acute and Chronic Esophageal Injury in Rodents